Eurofarma Laboratorios S.a.
Clinical trials sponsored by Eurofarma Laboratorios S.a., explained in plain language.
-
New drug aims to regrow hair in women with pattern baldness
Disease control Not yet recruitingThis study tests a new medicine called N1087 for women with female pattern hair loss. About 372 women will take either the drug or a placebo daily for 24 weeks. The goal is to see if the drug increases hair density and thickness in the scalp area. Researchers will also check safe…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 17, 2026 06:19 UTC
-
New asthma inhaler faces off against standard treatment in major trial
Disease control Not yet recruitingThis study tests a new inhaler medicine (N0783) to see if it works as well as a standard asthma inhaler (Alenia®) for people with moderate asthma. About 174 adults will take one of the two inhalers for 12 weeks. Researchers will measure lung function and symptom control to confir…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Baldness breakthrough? new pill aims to regrow hair
Symptom relief Not yet recruitingThis study tests a daily pill (N1087, a form of minoxidil) to see if it can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo for 24 weeks. The main goal is to measure changes in hair den…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated May 04, 2026 16:18 UTC